Zheng Yazhi, Chen Hanxu, Lin Xiang, Li Minli, Zhao Yuanjin, Shang Luoran
Department of Rheumatology and Immunology, Institute of Translational Medicine, Nanjing Drum Tower Hospital, School of Biological Science and Medical Engineering, Southeast University, Nanjing, 210096, China.
Chemistry and Biomedicine Innovation Center, Nanjing University, Nanjing, 210023, China.
Small. 2023 Apr;19(17):e2206007. doi: 10.1002/smll.202206007. Epub 2023 Feb 1.
Drug microcarriers are widely used in disease treatment, and microfluidics is well established in the preparation of microcarrier particles. A proper design of the microfluidic platform toward scalable production of drug microcarriers can extend its application values in wound healing, where large numbers of microcarriers are required. Here, a microfluidic step emulsification method for the preparation of monodisperse droplets is presented. The droplet size depends primarily on the microchannel depth rather than flow rate, making the system robust for high-throughput production of droplets and hydrogel microparticles. Based on this platform, basic fibroblast growth factor (bFGF) is uniformly encapsulated in the microparticles, and black phosphorus (BP) is incorporated for controllable release via near-infrared (NIR) stimulation. The microparticles serve as drug carriers to be applied to the wound site, inducing angiogenesis and collagen deposition, thereby accelerating wound repair. These results indicate that the step emulsification technique provides a promising solution to scalable production of drug microcarriers for wound healing as well as tissue regeneration.
药物微载体广泛应用于疾病治疗,而微流控技术在微载体颗粒的制备中已得到充分确立。针对可扩展生产药物微载体的微流控平台进行合理设计,可拓展其在伤口愈合中的应用价值,因为伤口愈合需要大量微载体。在此,提出了一种用于制备单分散液滴的微流控分步乳化方法。液滴大小主要取决于微通道深度而非流速,这使得该系统对于高通量生产液滴和水凝胶微粒具有鲁棒性。基于此平台,碱性成纤维细胞生长因子(bFGF)被均匀包裹在微粒中,并掺入黑磷(BP)以通过近红外(NIR)刺激实现可控释放。这些微粒作为药物载体应用于伤口部位,诱导血管生成和胶原蛋白沉积,从而加速伤口修复。这些结果表明,分步乳化技术为可扩展生产用于伤口愈合及组织再生的药物微载体提供了一种有前景的解决方案。